Coya Therapeutics shareholders approved auditor appointment for 2026 fiscal year

Coya Therapeutics held its annual stockholder meeting on June 25, 2026. Shareholders elected Wilbur Ross and Dieter Weinand as directors and ratified Weaver and Tidwell as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Coya Therapeutics held its annual stockholder meeting on June 25, 2026. * Shareholders elected two directors, Wilbur Ross and Dieter Weinand. * Shareholders ratified Weaver and Tidwell as independent registered public accounting firm for the year ending Dec. 31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-282989), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here